Wall Street Bets Lilly’s GLP-1 Portfolio, Missed $1T
Investors are placing massive bets on Eli Lilly’s GLP-1 drugs, but the push for a $1 trillion opportunity faces medic...
Find value-oriented index funds that maintain low fees in 2024. Understand how value funds can enhance long-term retirement portfolios.
24,728 articlesInvestors are placing massive bets on Eli Lilly’s GLP-1 drugs, but the push for a $1 trillion opportunity faces medic...
A seasoned investor’s eye looks beyond a single insider trade. This article breaks down why this limited insider sale...
In 2026, California's counties with highest property taxes are seeing bills rise as high-valued homes push costs up, ...
Greg Abel delivers his first annual letter as Berkshire’s CEO, outlining continuity after a $4.5 billion write-down o...
Major restaurant chains are testing smaller portions as inflation and weight-management trends push diners toward val...
Electric vehicle leaders are increasingly defined by their software and AI capabilities. This guide highlights three ...
Investors eye Omada Health as it reports Q1 2026 results. This analysis breaks down the earnings narrative, key metri...
Analysts tout gains for an overlooked tech name, but the upside may be clouded by rising costs, competition, and macr...
A major fund disclosed a $38 million stake in monday.com as the stock collapsed by about 75%. This article explains w...
As the clean energy shift accelerates, two hydrogen-focused leaders—Bloom Energy and Plug Power—offer distinct paths ...
In a live Fox Business showdown, Peter Schiff and Anthony Pompliano spar over Bitcoin's future. Schiff questions intr...
A crypto analyst challenges Ripple’s CEO over Strategy’s BTC funding model as BTC and XRP markets react to evolving f...